Puma Biotechnology Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include Takeda.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | |
Founding Date | Founding Date 1981 | Founding Date 1781 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | |
Employees | Employees 277161% increase | Employees 47,4554% decrease |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 43.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) ¥4.6t (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods ¥818.8b (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit ¥3.8t (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income ¥108.1b (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 57.8m |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company